| Literature DB >> 26499194 |
Jasmijn K Van Camp1, Fenna De Freitas1, Doreen Zegers1, Sigri Beckers1, Stijn L Verhulst2, Kim Van Hoorenbeeck2, Guy Massa3, An Verrijken4, Kristine N Desager2, Luc F Van Gaal4, Wim Van Hul5.
Abstract
The aim of this study was to confirm the previously identified link between BAMBI and human obesity by means of a genetic and functional analysis. We performed both a mutation analysis, using high-resolution melting curve analysis, and a genetic association study, including 8 common tagSNPs in the BAMBI gene region. Three of the identified genetic variants (R151W, H201R, and C229R) were evaluated for their Wnt signaling enhancing capacity in a Wnt luciferase reporter assay. Mutation screening of the BAMBI coding region and exon-intron boundaries on our population of 677 obese children and adolescents and 529 lean control subjects resulted in the identification of 18 variants, 10 of which were not previously reported and 12 of which were exclusively found in obese individuals. The difference in variant frequency, not taking into account common polymorphisms, between obese (3.1 %) and lean (0.9 %) subjects was statistically significant (p = 0.004). Our Wnt luciferase assay, using WT and mutant BAMBI constructs, showed a significantly reduced activity for all of the investigated variants. Logistic and linear regression analysis on our Caucasian population of 1022 obese individuals and 606 lean controls, did not identify associations with obesity parameters (p values >0.05). We found several rare genetic variations, which represent the first naturally occurring missense variants of BAMBI in obese patients. Three variants (R151W, H201R, and C229R) were shown to reduce Wnt signaling enhancing capacity of BAMBI and we believe this result should encourage further study of this gene in other obese populations. In addition, we did not find evidence for the involvement of BAMBI common variation in human obesity in our population.Entities:
Keywords: Bambi; Genetics; Human obesity; Wnt
Mesh:
Substances:
Year: 2015 PMID: 26499194 DOI: 10.1007/s12020-015-0778-4
Source DB: PubMed Journal: Endocrine ISSN: 1355-008X Impact factor: 3.633